Page last updated: 2024-12-05

angelica lactone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Angelica lactone is a naturally occurring coumarin derivative found in the roots of Angelica archangelica, a plant commonly used in traditional medicine. It exhibits various pharmacological activities, including anti-inflammatory, antioxidant, and antimicrobial effects. Research has shown that angelica lactone can inhibit the production of pro-inflammatory cytokines and reactive oxygen species, potentially contributing to its anti-inflammatory properties. The compound also displays antimicrobial activity against certain bacteria and fungi. Additionally, angelica lactone has been studied for its potential in treating conditions such as cancer, diabetes, and neurodegenerative diseases. Its synthesis involves various chemical reactions, and its importance lies in its potential applications in medicinal chemistry and the development of new therapeutic agents.'

angelica lactone: RN given refers to cpd without isomeric designation; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11558
CHEMBL ID47969
CHEBI ID36436
MeSH IDM0071580

Synonyms (88)

Synonym
beta-angelica lactone
5-methylfuran-2(5h)-one
beta-angelicalactone
delta(1)-angelica lactone
beta-angelicalacton
alpha,beta-angelica lactone
CHEBI:36436 ,
4-hydroxy-2-pentenoic acid gamma-lactone
gamma-methyl-alpha,beta-crotonolactone
1ax0ncs144 ,
5-17-09-00121 (beilstein handbook reference)
2-pentanoic acid, 4-hydroxy-, gamma-lactone
unii-1ax0ncs144
4-hydroxy-3-pentenoic acid lactone
nsc11835
17300-24-2
2-pentenoic acid, -.gamma.-lactone, dimer
5-methylfuran-2(5h)-one, dimer
nsc-11835
delta(sup1)-angelica lactone
einecs 209-700-2
2-pentenoic acid, 4-hydroxy-, gamma-lactone
ai3-61052
delta1-angelica lactone
delta(sup 1)-angelica lactone
brn 0108058
nsc 655
4-hydroxy-2-pentenoic acid, gamma-lactone
2-methyl-2h-furan-5-one
.alpha.,.beta.-angelica lactone
2(5h)-furanone, 5-methyl-
.beta.-angelica lactone
2-pentenoic acid, .gamma.-lactone
4-hydroxypent-2-enoic acid lactone
nsc655
nsc-655
.delta.(sup1)-angelica lactone
wln: t5ov ehj e1
.delta.1-angelica lactone
.gamma.-methyl-.alpha.,.beta.-crotonolactone
4-hydroxy-2-pentenoic acid .gamma.-lactone
2-penten-4-olide
.beta.(.alpha.,.beta. or .delta.1)-angelica lactone
591-11-7
.gamma.-methyl-.delta..alpha.,.beta.-butenolide
5-methyl-2(5h)-furanone
angelica lactone
CHEMBL47969
AKOS006278741
70428-45-4
(+-)-5-methyl-2(5h)-furanone
2(5h)-furanone, 5-methyl-, (+-)-
einecs 215-586-5
ccris 2925
fema no. 4438
2-oxo-5-methyl-2,5-dihydrofuran
angelica lactone .beta.-form [mi]
2-pentenoic acid, 4-hydroxy-, .gamma.-lactone
4-methyl-2-buten-4-olide
BGLUXFNVVSVEET-UHFFFAOYSA-N
.gamma.-methyl-.delta.,.alpha.,.beta.-butenolide
5-methyl-5h-furan-2-one
2(5h)-furanone, 5-methyl
AS-57863
3-pentenoic acid,4-hydroxy,lactone alpha-angelica-lactone
angelic lactone
laquo deltaraquo 2-angelica lactone
penten-3-oic acid, 4-hydroxy-, laquo gammaraquo -lactone
beta,laquo gammaraquo -angelica lactone
d2-angelica lactone
fema 3293
4-hydroxy-3-pentenoic acid g-lactone
3-pentenoic acid, 4-hydroxy-, laquo gammaraquo -lactone
penten-3-oic acid, 4-hydroxy-, gamma-lactone
alpha-angelic lactone
5-methyl-2(3h)-furanone (alpha -angelicalactone)
4-hydroxy-3-pentenoic acid laquo gammaraquo -lactone
alpha(alpha-angelica lactone
BBL102975
STL556784
mfcd01725808
5-methyl-2,5-dihydrofuran-2-one
Q27116831
DTXSID901014526
SB60927
CS-0152699
u6w ,
EN300-157325

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
angelica lactone
butenolideA gamma-lactone that consists of a 2-furanone skeleton and its substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID212820The rate constant in Acetonitrile and buffered aqueous acetonitrile solution, at 25 degrees Celsius and pH 7.41986Journal of medicinal chemistry, Sep, Volume: 29, Issue:9
Thiol addition to quinones: model reactions for the inactivation of thymidylate synthase by 5-p-benzoquinonyl-2'-deoxyuridine 5'-phosphate.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (36.84)18.7374
1990's1 (5.26)18.2507
2000's2 (10.53)29.6817
2010's6 (31.58)24.3611
2020's3 (15.79)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 35.93

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index35.93 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index5.31 (4.65)
Search Engine Demand Index43.64 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (35.93)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]